A Study of a Seasonal Trivalent Split, Inactivated Influenza Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Influenza, Human
Interventions
BIOLOGICAL

Influenza vaccine, split inactivated

Seasonal trivalent inactivated influenza vaccine (TIV), inactivated split virion, purified by sucrose gradient ultracentrifugation. The vaccine is produced in hen's eggs, and inactivated with beta-propiolactone.

OTHER

Placebo

0.5 mL of phosphate buffered saline

Trial Locations (1)

Unknown

Clinical Center of Serbia, Belgrade

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Department of Health and Human Services

FED

collaborator

World Health Organization

OTHER

collaborator

PATH

OTHER

collaborator

Comac Medical

INDUSTRY

lead

Institute of Virology, Vaccines and Sera, Torlak

OTHER